Search results
Pfizer Inc. (NYSE:PFE) Shares Sold by Waddell & Associates LLC
ETF DAILY NEWS· 12 hours agoWaddell & Associates LLC reduced its position in Pfizer Inc. (NYSE:PFE – Free Report) by 40.0% in the 4th quarter, according to its most recent disclosure with the Securities ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 10 hours agoThis is why empirical research shows a strong correlation between trends in earnings estimate...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with ...
Pfizer Inc. (NYSE:PFE) – Experts See The Stock A Different Way Today – Marketing Sentinel
Marketing Sentinel· 6 days agoAnalyst projections state that PFE is forecast to be at a low of $20 and a high of $141.39. Pfizer Inc. (PFE) estimates and forecasts Pfizer Inc.
Analysts reset Nvidia stock price targets amid split, Dow entry talk
TheStreet via Yahoo Finance· 9 hours agoNext stop: the Dow? The lower share price added to speculation that Nvidia could be added to the Dow...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 7 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 3 days agoIt's essential to do some research of our own. With that said, let's look at two dividend stocks...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 5 days agoNVAX shares are trading higher Wednesday, and the stock is up by more than 300% over the past month....
Latest trial over Zantac cancer claims called off as plaintiff drops case
Reuters· 39 minutes ago, opens new tab discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
The Motley Fool via AOL· 5 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...